Repligen Corp/ US7599161095 /

12/8/2023 9:59:57 PM	Chg. -2.53	Volume	Bid-	Ask-	High	Low
159.30USD	-1.56%	25,012 Turnover: 4.02 mill.	-Bid Size: -	-Ask Size: -	164.57	158.42

GlobeNewswire 3/18/2022 Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

GlobeNewswire 2/17/2022 Repligen Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 2/15/2022 Repligen Launches AAV Affinity Resins for Gene Therapy Purification

GlobeNewswire 2/11/2022 Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference

GlobeNewswire 2/3/2022 Repligen to Report Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 12/30/2021 Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 11/12/2021 Repligen Corporation to Present at Upcoming Investor Conferences

GlobeNewswire 11/12/2021 IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS

GlobeNewswire 11/5/2021 Repligen Releases Inaugural Sustainability Report

GlobeNewswire 10/28/2021 Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

GlobeNewswire 10/14/2021 Repligen to Report Third Quarter 2021 Financial Results

GlobeNewswire 10/5/2021 TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations

GlobeNewswire 9/16/2021 Repligen Announces Agreement to Acquire Avitide Inc.

GlobeNewswire 9/9/2021 Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH S...

GlobeNewswire 7/27/2021 Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

GlobeNewswire 7/13/2021 Repligen to Report Second Quarter 2021 Financial Results

GlobeNewswire 6/22/2021 Repligen Corporation Announces Agreement to Acquire Polymem S.A.

GlobeNewswire 5/25/2021 Repligen Corporation to Present at Upcoming Investor Conferences

GlobeNewswire 5/4/2021 Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

GlobeNewswire 4/20/2021 Repligen to Report First Quarter 2021 Financial Results

GlobeNewswire 4/15/2021 Entera Appoints Ramesh Ratan as Chief Financial Officer

GlobeNewswire 3/17/2021 Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

GlobeNewswire 3/3/2021 Repligen Corporation to Present at Barclays Global Healthcare Conference

GlobeNewswire 3/2/2021 Vaccitech Appoints Two Independent Board Directors

GlobeNewswire 2/24/2021 Repligen Reports Fourth Quarter and Full Year 2020 Financial Results